Considerable interest has been sparked in the potential application of osimertinib, a innovative medication for individuals with lung cancer, within the leptomeningeal cavity.Osimertinib leptomeningeal refers to the use of osimertinib for treating leptomeningeal metastasis, which is a difficult and frequently untreatable state.Several urgent requirements have emerged as researchers delve more thoroughly in this field, each requiring attention for the improvement of patient outcomes.The need to comprehend how osimertinib interacts with leptomeningeal metastases is the above all.By providing insights into the drug's effectiveness and possible adverse effects, this understanding will guide…
